Designing the safety of healthcare. Participation of ergonomics to the design of cooperative systems in radiotherapy

This communication deals with the involvement of ergonomists in a research-action design process of a software platform in radiotherapy. The goal of the design project is to enhance patient safety by designing a workflow software that supports cooperation between professionals producing treatment in radiotherapy. The general framework of our approach is the ergonomics management of a design process, which is based in activity analysis and grounded in participatory design. Two fields are concerned by the present action: a design environment which is a participatory design process that involves software designers, caregivers as future users and ergonomists; and a reference real work setting in radiotherapy. Observations, semi-structured interviews and participatory workshops allow the characterization of activity in radiotherapy dealing with uses of cooperative tools, sources of variability and non-ruled strategies to manage the variability of the situations. This production of knowledge about work searches to enhance the articulation between technocentric and anthropocentric approaches, and helps in clarifying design requirements. An issue of this research-action is to develop a framework to define the parameters of the workflow tool, and the conditions of its deployment.     

The recent history of the IEA: an analysis of IEA Congress presentations since 1961

In this paper we review historical material relating to the growth and coverage of past IEA meetings and congresses. In particular, we report on presentations at IEA Congresses dating back to the first one in Stockholm in 1961. A content analysis of Congress proceedings was carried out and we present findings on changes since 1961 covering: numbers and nationalities of conference participants and the types of topics presented at Congresses. Our findings point to evidence of widening participation at the conferences, in particular delegates drawn from Asia, South East Asia and the Far East. In addition, some topics (e.g., physiology, methodological papers and studies of workload) appear to have waned in popularity over the period, whereas some topics (e.g., ODAM, Cognitive Ergonomics) have grown in popularity. We discuss these findings in the light of other evidence covering historical trends and developments within human factors and ergonomics.     

Online epistemic communities: theoretical and methodological directions for understanding knowledge co-elaboration in new digital spaces

This paper presents, illustrates and discusses a generic framework for studying knowledge co-elaboration in online epistemic communities ("OECs"). Our approach is characterised by: considering knowledge co-elaboration as a design activity; distinguishing discussion and production spaces in OECs; characterising participation via the notion of role; fine-grained analyses of meaning, content and communicative functions in interactions. On this basis, three key issues for ergonomics research on OECs are discussed and illustrated by results from our previous studies on OSS and Wikipedia. One issue concerns the interrelation between design (task) and regulation. Whereas design task-oriented activity is distributed among participants, we illustrate that OCEs function with specialised emerging roles of group regulation. However, the task-oriented activity also functions at an interpersonal level, as an interplay of knowledge-based discussion with negotiation of competencies. Another issue concerns the foci of activity on the (designed) knowledge object. Based on a generic task model, we illustrate asymmetry and distinctiveness in tasks' foci of participants. The last issue concerns how design-use mediation is ensured by specific forms of mediation roles in OECs. Finally we discuss the degree of generality of our framework and draw some perspectives for extending our framework to other OECs.     

Return Schemes from European Countries: Assessing the Challenges

Drawing on a review of the academic literature on return migration and return migration policies, as well as on reports and project documentation, this article provides a general assessment of return schemes from European countries, with a focus on those targeting failed asylum‐seekers and irregular migrants. The article first highlights the contrasted understanding of return and reintegration by migration policy‐makers and migration scholars respectively. It then provides an overview of the main challenges, focusing on seven key issues: preparedness to return, the imbalance of represented interests, legal mobility, conditions in the countries of origin, the reintegration package, integration in Europe, and the specific obstacles to return faced by failed asylum‐seekers. The article highlights the need to reassess return policies and frame more realistic schemes.     

Intimate tablets: digital advocacy and post-feminist pharmaceuticals

Since the enormous commercial success of Viagra, launched by Pfizer in 1998, large pharmaceutical conglomerates have sought to produce an analogous drug for women with low sexual desire. On August 18 2015, Sprout Pharmaceuticals obtained approval from the Food and Drugs Administration (FDA) for flibanserin, now marketed as Addyi. In the lead-up to the approval of Addyi, campaigns supporting the production of the drug were deployed through an extensive use of social and digital media platforms including Facebook and Twitter, which mobilised discourses of post-feminism to reconfigure narratives of intimacy to lobby the FDA. The lobbying for the approval of the tablet represents a unique instance of consumers reproducing discourses of medicalisation in order to demand gender equality. It strategically combines feminist rhetoric and digital media platforms to disseminate and coordinate such demands. The rhetoric of post-feminism constitutes both a reproduction of discourses of medicalisation and a challenge to medical orthodoxy. The success of the campaigns exemplifies a turn in the pharmaceutical industry where potential consumers are also producers of medical products, no longer passive but active agents in the commodification of pharmaceutical intimacy and the management of sexual desire.